Sunflower Pharmaceutical GroupLtd Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Sunflower Pharmaceutical GroupLtd.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 19.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability
Nov 04
A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)
Aug 26Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E
Jul 19Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 07Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders
May 06Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity
Apr 16We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease
Mar 04In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sunflower Pharmaceutical GroupLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 4,432 | 855 | -15 | 103 | N/A |
| 6/30/2024 | 5,194 | 967 | 254 | 372 | N/A |
| 3/31/2024 | 5,453 | 968 | 718 | 845 | N/A |
| 12/31/2023 | 5,700 | 1,119 | 741 | 890 | N/A |
| 9/30/2023 | 6,100 | 1,209 | 1,436 | 1,582 | N/A |
| 6/30/2023 | 5,879 | 1,104 | 1,711 | 1,859 | N/A |
| 3/31/2023 | 5,662 | 1,054 | 1,670 | 1,794 | N/A |
| 1/1/2023 | 5,095 | 867 | 1,822 | 1,975 | N/A |
| 9/30/2022 | 4,675 | 813 | 1,112 | 1,252 | N/A |
| 6/30/2022 | 4,608 | 799 | 749 | 908 | N/A |
| 3/31/2022 | 4,443 | 698 | 925 | 1,075 | N/A |
| 1/1/2022 | 4,461 | 705 | 747 | 865 | N/A |
| 9/30/2021 | 4,271 | 668 | 775 | 914 | N/A |
| 6/30/2021 | 3,964 | 655 | 978 | 1,166 | N/A |
| 3/31/2021 | 3,769 | 656 | 930 | 1,143 | N/A |
| 12/31/2020 | 3,462 | 584 | 957 | 1,170 | N/A |
| 9/30/2020 | 3,427 | 509 | 886 | 1,184 | N/A |
| 6/30/2020 | 3,585 | 497 | 699 | 1,012 | N/A |
| 3/31/2020 | 4,069 | 557 | 698 | 1,052 | N/A |
| 12/31/2019 | 4,371 | 565 | 607 | 981 | N/A |
| 9/30/2019 | 4,488 | 591 | 684 | 1,028 | N/A |
| 6/30/2019 | 4,523 | 586 | 700 | 1,013 | N/A |
| 3/31/2019 | 4,594 | 580 | 538 | 882 | N/A |
| 12/31/2018 | 4,472 | 563 | 545 | 866 | N/A |
| 9/30/2018 | 4,369 | 524 | 578 | 820 | N/A |
| 6/30/2018 | 4,234 | 515 | N/A | 639 | N/A |
| 3/31/2018 | 4,111 | 472 | N/A | 689 | N/A |
| 12/31/2017 | 3,855 | 424 | N/A | 567 | N/A |
| 9/30/2017 | 3,855 | 426 | N/A | 490 | N/A |
| 6/30/2017 | 3,785 | 328 | N/A | 524 | N/A |
| 3/31/2017 | 3,435 | 305 | N/A | 230 | N/A |
| 12/31/2016 | 3,364 | 303 | N/A | 341 | N/A |
| 9/30/2016 | 3,045 | 230 | N/A | -71 | N/A |
| 6/30/2016 | 3,057 | 291 | N/A | -111 | N/A |
| 3/31/2016 | 3,094 | 319 | N/A | 93 | N/A |
| 12/31/2015 | 3,035 | 307 | N/A | 126 | N/A |
| 9/30/2015 | 2,981 | 307 | N/A | 211 | N/A |
| 6/30/2015 | 2,980 | 319 | N/A | 382 | N/A |
| 3/31/2015 | 2,820 | 312 | N/A | 421 | N/A |
| 12/31/2014 | 2,719 | 301 | N/A | 403 | N/A |
| 9/30/2014 | 2,567 | 268 | N/A | 425 | N/A |
| 12/31/2013 | 2,181 | 263 | N/A | 293 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 002737's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 002737's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 002737's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 002737's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 002737's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 002737's Return on Equity is forecast to be high in 3 years time